Objectives. To determine the extent to which therapeutics textbooks address age-related medication information. Methods. Criteria for 5 disease states prevalent among geriatric patients were developed based on the content of a geriatric textbook and from expert reviewers' input. The criteria were used to determine the degree to which geriatric content was addressed in 3 therapeutics textbooks.
INTRODUCTION
The number of elderly Americans (those over 65 years of age) is anticipated to grow to 70 million people by the year 2030. 1 This would represent an increase from nearly 13% of the US population in 2000 to approximately 20%. 1 In response to the increased burden that this demographic shift will place on the US health care system, colleges of pharmacy must ensure that future practitioners are prepared to manage the health care needs of the elderly population.
Managing medication issues for geriatric patients is often incorporated into therapeutics courses 1 and these courses typically require one of the following textbooks: Applied Therapeutics: The Clinical Use of Drugs; Pharmacotherapy: A Pathophysiologic Approach; or Textbook of Therapeutics: Drug and Disease Management.
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The intent of this study was to determine the extent to which these therapeutics textbooks address important age-related medication use information.
METHODS
Five disease states were chosen for review because of their prevalence in the elderly population, importance of medications in the management of the condition, and unique care issues in the management of the condition within the elderly population. The 5 disease states were osteoarthritis, dementia, diabetes mellitus, chronic obstructive pulmonary disease (COPD), and heart failure.
For each disease state, criteria for important pharmacotherapy issues for geriatric patients were created and are referred to as ''Critical Points in Geriatric Care.'' The initial draft of the criteria was created by the investigators and was based on coverage of the targeted disease states in the textbook Principles of Geriatric Medicine & Gerontology. 5 Once the first draft of the criteria was completed, 2 national experts in the specific area were identified and invited to participate in the project. These experts were chosen based on their national certification, publication, and presentation record. The experts were not authors of the corresponding chapter in any of the therapeutics textbooks analyzed in this study. The first draft of the criteria was sent to the 2 content experts and they provided suggestions for additions, deletions, or corrections. Their input was reviewed by the investigators and utilized to create the final ''Critical Points in Geriatric Care'' for each disease state (Appendix). Criteria were divided into ''important issues'' that were aspects necessary for quality geriatric care but not specific to the elderly and ''unique issues'' that were essential issues specific to the elderly population. For example, the fact that nonsteroidal anti-inflammatory drugs (NSAIDs) can exacerbate heart failure is an ''important issue'' in treating elderly patients, while age being a strong predictor of gastrointestinal ulcers induced by NSAIDs is a ''unique issue'' to this population. The number and type of criteria for each disease state are found in Table 1 .
Two investigators reviewed each disease state within the 3 therapeutics textbooks. [2] [3] [4] The review included examining the chapter on the disease state and any other chapters in the textbooks dealing with aging that also addressed the topic. Each investigator indicated whether each criterion was present or not present and noted the page number where the information was located. When only a portion of the criteria was present or there was speculation as to the presence of the item, notes were provided by the investigator on the evaluation form. Two investigators reviewed each disease state in each of the 3 textbooks.
One of the investigators tabulated all of the evaluation sheets for ''Critical Points in Geriatric Care.'' If a portion of the criteria was present, partial credit was awarded. Results from the 2 investigators were averaged to create a final percentage of critical points for the disease state within each textbook. These values were then averaged to produce a percentage of critical points for each disease state that was typically covered in therapeutics textbooks. Table 2 lists the mean percentage of criteria in each textbook. The mean percentage ranged from 15% to 78%. When combined, the average of all 3 textbooks contained the fewest critical points for the COPD chapters and the dementia chapters contained the highest percentage of critical points. The average percentages of criteria addressed in the 3 textbooks by category (important issue or unique issue) is presented in Table 3 . Important issues were mentioned more frequently than unique issues.
RESULTS

DISCUSSION
The current editions of the therapeutics textbooks commonly used in pharmacy education vary in the extent to which they address geriatric pharmacotherapy information. With the curricular practice of incorporating geriatric pharmacy care education into therapeutics topics, 1 students and faculty members often rely on therapeutics textbooks for information on medication use in the elderly population. Popular therapeutics textbooks typically contain less than half of the critical points on the disease states of COPD, heart failure, and diabetes mellitus (31%, 33%, and 46%, respectively). In addition, these therapeutics textbooks address one half to two thirds of the criteria for the remaining 2 disease states of osteoarthritis and dementia (55% and 68%, respectively). These omissions may lead to significant gaps in student learning in these common chronic conditions. Table 2 shows an even greater concern with individual textbooks on select disease states. For example, only 15% of the COPD criteria and 20% of the diabetes mellitus criteria were covered by one of the textbooks. No textbook scored highest or lowest on all 5 disease states. However, one textbook was highest in 4 of the 5 disease states and one was lowest on 3 of the 5 disease states. These data indicate that all textbooks have limitations. The geriatric content contained within a chapter may depend upon the chapter author's expertise and knowledge in geriatric pharmacotherapy.
Related to the specific type of information that is addressed, the ''important issues'' were included more often than the ''unique issues'' for all 5 disease states ( Table 3 ). The average percentage of criteria in the categories of ''important issues'' and ''unique issues'' was 63% and 38%, respectively. This pattern of inclusion indicates that general information relevant to care of the elderly is included more often than information specifically addressing care of the elderly patient. The low percentages of unique issues contained in these therapeutics textbooks highlight important shortcomings. Many of the unique issues in the criteria are frequently responsible for adverse events in the older population that often go unrecognized as drug-induced problems. Care must be taken to include research and pharmacotherapy information that specifically addresses care of the elderly and not just issues that are relevant to all populations. Although it is not expected that each chapter reviewed would contain all criteria, in our opinion, those with less than 50% of important pharmacotherapy issues need improvement. With the explosion of new drug therapy knowledge, it is difficult for editors to incorporate all information and still limit the size of the book to a reasonable number of pages. However, as the geriatric population increases, more attention must be given in therapeutics textbooks to the unique drug therapy needs of the elderly. Future editions of the 3 textbooks reviewed in this study should incorporate more geriatric-specific content in appropriate chapters.
Currently, in order to address these omissions, faculty and students cannot rely on the textbooks as a complete resource and must either conduct a careful review of the geriatric literature on each disease state or identify an appropriate geriatrics textbook. However, there are currently few geriatric textbooks available and many of these lack focus on specific drug therapy management. [6] [7] [8] There are several limitations to this study that must be considered in evaluating these results. First, the criteria are not exhaustive and there may be other equally important issues that were not included. However, the intent of the project was to provide a sample of important issues and determine the extent of coverage. Second, applying the criteria to the textbooks by the reviewers yielded variation in results. This may have been due to the need for the reviewer to discern whether the item was included in a text. Sometimes an item was addressed in an indirect fashion or the issue was raised but age-related information was not included. In addition, some of the variability may be explained by difficulty finding information; in some cases the criteria were implicit and easy for a chapter reviewer to miss. Because our criteria were not always stated in similar terms as those used in the books, some interpretation by the chapter reviewers was required and also may have contributed to the variability in data. Third, the textbook used as the basis for the criteria was published in 2003. 5 The potential exists for the criteria to no longer be relevant. However, the pharmacotherapy experts who reviewed the critical points helped assure the criteria were current. Fourth, this study used therapeutics textbooks that were available between July 2005 and January 2006. New editions of these textbooks are published regularly and may address age-related issues to a greater or lesser degree. Therefore, these results might not be applicable to future editions of the texts if significant revisions are made. Lastly, the 5 disease states examined in each textbook represent a small percentage of the content of each book and may not be representative of the entire book. However, the disease states chosen are among the most common chronic diseases in the elderly. It is plausible that the reviewed disease states are an accurate reflection of the geriatric-specific content within other chapters that have relevance to older patients. 
CONCLUSION
Currently available therapeutics textbooks have significant gaps in their coverage of geriatric drug therapy information. In order to address these omissions, faculty members and students using these textbooks need to either carefully review the literature on geriatric issues related to the disease state or identify a supplementary textbook that focuses on geriatrics. The latter may require the publication of a new textbook on geriatrics since currently there are few texts available on medication use in the elderly population.
Appendix 1. Critical Points in Geriatric Care
Critical Points in Geriatric Care
Relevance of Issue COPD COPD is a disease characterized by chronic, progressive airflow limitation caused by chronic bronchitis and /or emphysema seen predominately in those over 65 years of age. 
Unique Work-up for dementia should rule out reversible causes of cognitive change (e.g., deficiencies in B 12 or TSH).
Important
Depression in the elderly can produce symptoms similar to dementia and therefore must be ruled out. Unique Elderly are at increased risk of delirium: Unique a. post operatively b. with medication changes c. from drug interactions Age is the most important risk factor for Alzheimer's disease. Unique Medications may produce cognitive deficits in the elderly and therefore it is very important to obtain a list of the patient's prescription and over-the-counter medications.
Unique
Behaviors associated with dementia are managed with environmental modification and medications as appropriate.
Important
Atypical antipsychotic agents are the preferred treatment for psychosis, agitation, and aggression associated with dementia.
Very low doses of atypical antipsychotic agents are used in the situations described above for the elderly.
Unique
Acetylcholinesterase inhibitors may slow cognitive decline. Important Significant improvement in cognitive function from cholinesterase inhibitors occurs in a minority of patients.
Important
Acetylcholinesterase inhibitors may improve activities of daily living. Important Acetylcholinesterase inhibitors may improve behavioral problems. Important A patient with Alzheimer's disease who fails to respond to an acetylcholinesterase inhibitor or loses efficacy after responding may respond to a different acetylcholinesterase inhibitor.
Any drug with anticholinergic properties has the potential to cause delirium or cognitive dysfunction in elderly people.
Unique
Some NSAIDs have been shown to cause memory impairment and cognitive changes in elderly people.
Behaviors associated with dementia may be managed with psychotropic agents other than antipsychotic medications (e.g., anticonvulsants, trazodone). 
Important
Diabetes Mellitus
Unique
Considerations for not setting strict goals in patients with short life expectancy. Important Glyburide has a higher frequency of hypoglycemia in elderly. Unique Metformin is contraindicated in patients with heart failure requiring pharmacologic treatment or renal disease or dysfunction.
Important
Thiazolidinediones are not recommended in patients with heart failure (NYHA class 3 or 4). Important The combination of insulin and a thiazolidinedione is to be used with caution because of the agents' additive effects on fluid retention.
Effects of interventions on quality of life should be taken into account in any diabetes treatment plan. Important Regular assessment of treatment goals and management skills (potentially influenced by dexterity and vision changes) and reinforcement of education are necessary in the elderly whose functional and cognitive status may change over short periods of time.
Unique
Heart Failure There is an exponential increase in the prevalence of heart failure with aging due to age related changes in the cardiovascular system and age related increase in the prevalence of cardiovascular disease.
Four changes contributed to the elderly patient's inability to increase cardiac output in response to stress: Unique a. Decreased responsiveness of beta receptors to stimulation b. Increased vascular stiffness c. Altered ventricular filling during diastole d. Altered energy metabolism in the myocardium Age related changes in kidney function cause elderly patients to be: Unique a. Less able to correct volume overload and maintain electrolytes b. Less responsive to diuretics c. More likely to have electrolyte abnormalities from diuretic therapy Impaired thirst that occurs with aging may lead to dehydration and volume depletion in patients treated with diuretics.
Reduced functionality of carotid baroreceptors increases risk of orthostatic hypotension or syncope and makes some drugs used to treat heart failure more likely to cause these types of problems in the elderly. 
